After Yusimry’s discount, future prices for Adalimumab are unclear
Adalimumab, sold under the brand name Humira, has long been one of the best-selling drugs in the world. But its 20-year period without competition has ended, and despite its best…
Column: Merck says it was “forced” to negotiate drug prices with Medicare. This is nonsense
No one really expected the pharmaceutical industry to sit back and accept when Congress authorized Medicare to begin negotiating the prices of the prescription drugs it buys for enrollees. By…